Immutable evidence record · ticker
Liminatus Pharma, Inc. Class A Common Stock (LIMN)
Published as observed on 16 August 2026 at 03:08 BST.
Liminatus Pharma, Inc. Class A Common Stock has a balanced company news read. Its latest completed weekly trend is negative.
- As of
- 16 Aug 2026, 03:08
- Scope
- company and instrument
- Evidence
- 21 items
- Independent sources
- 1
- Country
- United States
- Sector
- Healthcare
- Previous read
- 50.000
- Change
- —
Verification
Evidence links
This is dated market research. Coverage may be delayed, incomplete or unavailable.
Cite this record:
Sharemaestro, Liminatus Pharma, Inc. Class A Common Stock (LIMN), 2026-08-16, https://sharemaestro.com/evidence/27fba67d-1e26-4c29-8df2-95cf12aa00c1/
Record checksum f8aa0602c33b2438a06eabf08890f0b44e8f77eaa992825b9ced95521f9a9425
